The Netherlands-based company provides testing supplies for infectious diseases, including coronavirus.
The $5.2 billion acquisition of Patheon positions Thermo Fisher to grab a slice of the fast-growing contract drug production business.
The lab equipment firm's $4.2 billion purchase of FEI gives it access to technology used by biopharma companies to develop drugs.
Nike, Avery Dennison, Thermo Fisher Scientific, Flowserve, Investors Real Estate, Altitude Digital, Albany Molecular, Pacific Specialty Insurance, Radisys
